FDA Investigator Ronald T Colucci
Ronald T Colucci has conducted inspections on 49 sites in 1 countries as of 26 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
26 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ronald T Colucci:
Abdellah El Hajjam,
Albert A Salvador,
Anita R Michael,
Antoinette L Ravelli,
Audrey Thereset Uy,
Austin B Appler,
Barbara A Kitay,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Calvin W Edwards,
Cara M Minelli,
Carol A Robles,
CDR Michael J Mero,
Crayton Lee,
Crystal A Harlan,
Cynthia White,
Daniel W Johnson,
Darlene C Plank Turlington,
Dauksism,
David A Schwartz,
David L Pearce,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Derek S Dealy,
Devon Jenkins,
Donald W Myrick,
Edward D Mcdonald,
Edwin L Hobbs,
Eric S Myskowski,
Erik A Bungo,
Erika M Wilkerson,
Gayle S Lawson,
Gerald W Kopp,
Giovanni A Vigilante,
Hala L Selby,
Howard B Rabinovitch,
James M Mason,
James P Mcevoy,
Jeannie R Mayberry,
Jeen S Min,
Jo Annc Declement,
Joseph Brady,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Julianne C Mccullough,
Kendra L Brooks,
Kim G Campbell,
Kristina J Donohue,
Krystyna M Kitson,
Kyle S Hobson,
LCDR Margaret Edi Gennaro,
LCDR Susan E Polifko,
Linda M Hoover,
Linda M Ross,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael A Taylor,
Michael D Omeara,
Michael Rosner,
Michele M Falchek,
Nikisha M Bolden,
Pamela M Tremarki,
Raymond L Cheung,
Richard E Jewell,
Robert W Calais,
Russell P Vandermark,
Sarah K Lemin,
Sean D Duke,
Seng Ching Hwang,
Shelley L Waring,
Stephanie Mangigian, MS/OSH, RN,
Tammy M Phillips,
Teigan M Mule,
Thomas E Friel,
Timothy J Schmidt,
Todd J Maushart,
Tonya O Corbin,
Van Cliff,
Vlada Matusovsky,
William C Brenneman,
William J Muszynski,
William W Dotts,
Willy A Orantes
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more